1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Personal Mobility Devices Market
2.2. Global Personal Mobility Devices Market, By Product, 2023 (US$ Million)
2.3. Global Personal Mobility Devices Market, By Geography, 2023 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2023

3. Personal Mobility Devices Market: Competitive Analysis
3.1. Market Positioning of Key Personal Mobility Devices Market Vendors
3.2. Strategies Adopted by Personal Mobility Devices Market Vendors
3.3. Key Industry Strategies
4. Personal Mobility Devices Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Personal Mobility Devices Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Wheelchairs
5.3.1.1. Manual Wheelchairs
5.3.1.2. Powered Wheelchairs
5.3.2. Scooters
5.3.3. Walking Aids
5.3.3.1. Canes and Crutches
5.3.3.2. Rollators
5.3.4. Patient Lifts
5.3.5. Patient Stairs


6. North America Personal Mobility Devices Market, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
6.3.Personal Mobility Devices Market: By Region, 2022-2032, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)

7. UK and European Union Personal Mobility Devices Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
7.3.Personal Mobility Devices Market: By Region, 2022-2032, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
7.3.1.5. France
7.3.1.5.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)

8. Asia Pacific Personal Mobility Devices Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
8.3.Personal Mobility Devices Market: By Region, 2022-2032, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
8.3.1.3. India
8.3.1.3.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)

9. Latin America Personal Mobility Devices Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
9.3.Personal Mobility Devices Market: By Region, 2022-2032, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)

10. Middle East and Africa Personal Mobility Devices Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
10.3.Personal Mobility Devices Market: By Region, 2022-2032, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Personal Mobility Devices Market: By Product, 2022-2032, USD (Million)

11. Company Profile
11.1. Carex Health Brands, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Drive Medical Design & Manufacturing
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Graham-Field Health Products Inc.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Invacare
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Kaye Products
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Briggs Healthcare (MABIS)
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Medline
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Nova Medical
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Patterson Medical
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Garden City Medical, Inc. (Proboscis)
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
11.11. Rollz
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Portfolio
11.11.4. Strategic Initiatives
11.12. Topro
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Portfolio
11.12.4. Strategic Initiatives
11.13. Eurovema AB (Volaris)
11.13.1. Company Overview
11.13.2. Financial Performance
11.13.3. Product Portfolio
11.13.4. Strategic Initiatives
11.14. Dana Douglas
11.14.1. Company Overview
11.14.2. Financial Performance
11.14.3. Product Portfolio
11.14.4. Strategic Initiatives
11.15. ETAC
11.15.1. Company Overview
11.15.2. Financial Performance
11.15.3. Product Portfolio
11.15.4. Strategic Initiatives
11.16. Airgo
11.16.1. Company Overview
11.16.2. Financial Performance
11.16.3. Product Portfolio
11.16.4. Strategic Initiatives
11.17. Better Medical Technology Co. Ltd
11.17.1. Company Overview
11.17.2. Financial Performance
11.17.3. Product Portfolio
11.17.4. Strategic Initiatives
11.18. Pride Mobility Products Corporation
11.18.1. Company Overview
11.18.2. Financial Performance
11.18.3. Product Portfolio
11.18.4. Strategic Initiatives
11.19. Sunrise Medical LLC63
11.19.1. Company Overview
11.19.2. Financial Performance
11.19.3. Product Portfolio
11.19.4. Strategic Initiatives
11.20. Permobil AB.64
11.20.1. Company Overview
11.20.2. Financial Performance
11.20.3. Product Portfolio
11.20.4. Strategic Initiatives
11.21. Hill-Rom Holdings, Inc.
11.21.1. Company Overview
11.21.2. Financial Performance
11.21.3. Product Portfolio
11.21.4. Strategic Initiatives